Neal Franklin Fowler, Director at Emergent BioSolutions Inc. (EBS), sold 35,000 shares at $5.83 ($204K) on 2025-03-12, disclosed to the SEC on 2025-03-12.
Open-market sale of $204k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.